Please enable JavaScript to continue using this application.

Compare $GRAL vs $PRAX | Chartloom

Compare

$GRAL vs $PRAX

Grail Inc · Praxis Precision Medicines Inc

GRAL

Grail Inc

PRAX

Praxis Precision Medicines Inc

Compare $GRAL vs $PRAX

Comparing Grail Inc and Praxis Precision Medicines Inc

GRALGrail Inc

PRAXPraxis Precision Medicines Inc

GRALGrail Inc

Market cap

$6.03B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

29.71x

Rev growth (TTM)

23.1%

YTD performance

58.2%

52W performance

123.8%

FCF yield

-4.9%

PRAXPraxis Precision Medicines Inc

Market cap

$7.24B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

67.04x

Rev growth (TTM)

—

YTD performance

-9.3%

52W performance

378.7%

FCF yield

-4.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GRAL

PRAX

Detailed metrics comparison

GRAL

Grail Inc

PRAX

Praxis Precision Medicines Inc

Market Cap

GRAL$6.03B

PRAX$7.24B

Enterprise Value

GRAL$5.98B

PRAX$6.77B

Price

GRAL$140.58

PRAX$259.86

P/E Ratio

GRALN/A

PRAXN/A

P/S Ratio

GRAL36.51x

PRAX964.65x

EV/Sales

GRAL36.17x

PRAX909.14x

EV/EBITDA

GRAL0.00x

PRAX0.00x

P/B Ratio

GRAL2.52x

PRAX6.15x

P/FCF Ratio

GRALN/A

PRAXN/A

EV/FCF

GRAL-20.19x

PRAX-22.11x

PEG Ratio

GRALN/A

PRAXN/A

Forward P/E (NTM)

GRALN/A

PRAXN/A

Forward P/S (NTM)

GRAL29.71x

PRAX67.04x

Revenue (TTM)

GRAL$165M

PRAX$0

Revenue Growth (YoY)

GRAL23.1%

PRAXN/A

Forward Rev Growth

GRAL25.3%

PRAX38349.0%

Gross Margin (TTM)

GRAL49.7%

PRAX0.0%

Operating Margin (TTM)

GRAL0.0%

PRAX0.0%

EBITDA Margin (TTM)

GRAL-229.0%

PRAX0.0%

Net Margin (TTM)

GRAL-236.9%

PRAX0.0%

FCF Margin (TTM)

GRAL-179.2%

PRAXN/A

Net Income (TTM)

GRAL$-392M

PRAX$-255M

FCF (TTM)

GRAL$-296M

PRAX$-306M

EPS (TTM)

GRAL-$9.08

PRAX$0.00

ROE (TTM)

GRAL-1588.0%

PRAX-4302.0%

ROA (TTM)

GRAL-1402.0%

PRAX-4022.0%

ROIC (TTM)

GRAL-1588.0%

PRAX-4302.0%

Cash

GRAL$56M

PRAX$475M

Debt

GRAL$0

PRAX$0

Net Cash/Debt

GRAL$56M

PRAX$475M

Current Ratio (TTM)

GRAL10.95x

PRAX15.73x

Quick Ratio (TTM)

GRAL10.55x

PRAX15.46x

Debt/Equity (TTM)

GRAL0.00x

PRAX0.00x

Debt/Assets (TTM)

GRAL0.0%

PRAX0.0%

Interest Coverage (TTM)

GRALN/A

PRAXN/A

Net Debt/EBITDA (TTM)

GRAL0.00x

PRAX0.00x

Beta

GRAL2.04

PRAX2.88

52W Performance

GRAL123.8%

PRAX378.7%

YTD Performance

GRAL58.2%

PRAX-9.3%

% from 52W High

GRAL-15.6%

PRAX-33.8%

% from 52W Low

GRAL238.7%

PRAX414.0%

Asset Turnover (TTM)

GRAL0.06x

PRAX0.02x

FCF Yield (TTM)

GRAL-4.9%

PRAX-4.2%

Earnings Yield (TTM)

GRAL-6.5%

PRAX-3.5%

Dividend Yield (TTM)

GRALN/A

PRAXN/A

Rule of 40

GRAL-156.1

PRAX0.0

EV/GP/RG

GRAL2.75

PRAXN/A

Ticker research

View GRAL research View PRAX research

Metric	GRAL Grail Inc	PRAX Praxis Precision Medicines Inc
Market & Valuation
Market Cap	$6.03B	$7.24B
Enterprise Value	$5.98B	$6.77B
Price	$140.58	$259.86
P/E Ratio	N/A	N/A
P/S Ratio	36.51x	964.65x
EV/Sales	36.17x	909.14x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.52x	6.15x
P/FCF Ratio	N/A	N/A
EV/FCF	-20.19x	-22.11x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	29.71x	67.04x
Revenue & Growth
Revenue (TTM)	$165M	$0
Revenue Growth (YoY)	23.1%	N/A
Forward Rev Growth	25.3%	38349.0%
Profitability
Gross Margin (TTM)	49.7%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-229.0%	0.0%
Net Margin (TTM)	-236.9%	0.0%
FCF Margin (TTM)	-179.2%	N/A
Net Income (TTM)	$-392M	$-255M
FCF (TTM)	$-296M	$-306M
EPS (TTM)	-$9.08	$0.00
ROE (TTM)	-1588.0%	-4302.0%
ROA (TTM)	-1402.0%	-4022.0%
ROIC (TTM)	-1588.0%	-4302.0%
Financial Health
Cash	$56M	$475M
Debt	$0	$0
Net Cash/Debt	$56M	$475M
Current Ratio (TTM)	10.95x	15.73x
Quick Ratio (TTM)	10.55x	15.46x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.04	2.88
52W Performance	123.8%	378.7%
YTD Performance	58.2%	-9.3%
% from 52W High	-15.6%	-33.8%
% from 52W Low	238.7%	414.0%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.02x
FCF Yield (TTM)	-4.9%	-4.2%
Earnings Yield (TTM)	-6.5%	-3.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-156.1	0.0
EV/GP/RG	2.75	N/A
Ticker research	View GRAL research	View PRAX research

Valuation

P/S Ratio

GRAL

36.51x

PRAX

964.65x

EV/FCF

PRAX

-22.11x

GRAL

-20.19x

Growth & revenue

Revenue Growth TTM

GRAL

23.1%

Forward Revenue Growth

PRAX

38349.0%

GRAL

25.3%

Profitability & performance

Gross Margin

GRAL

49.7%

PRAX

0.0%

ROE

GRAL

-1588.0%

PRAX

-4302.0%

FCF Yield %

PRAX

-4.2%

GRAL

-4.9%

52-Week Performance

PRAX

378.7%

GRAL

123.8%

Detailed metrics comparison

GRAL

Grail Inc

PRAX

Praxis Precision Medicines Inc

Market Cap

GRAL$6.03B

PRAX$7.24B

Enterprise Value

GRAL$5.98B

PRAX$6.77B

Price

GRAL$140.58

PRAX$259.86

P/E Ratio

GRALN/A

PRAXN/A

P/S Ratio

GRAL36.51x

PRAX964.65x

EV/Sales

GRAL36.17x

PRAX909.14x

EV/EBITDA

GRAL0.00x

PRAX0.00x

P/B Ratio

GRAL2.52x

PRAX6.15x

P/FCF Ratio

GRALN/A

PRAXN/A

EV/FCF

GRAL-20.19x

PRAX-22.11x

PEG Ratio

GRALN/A

PRAXN/A

Forward P/E (NTM)

GRALN/A

PRAXN/A

Forward P/S (NTM)

GRAL29.71x

PRAX67.04x

Revenue (TTM)

GRAL$165M

PRAX$0

Revenue Growth (YoY)

GRAL23.1%

PRAXN/A

Forward Rev Growth

GRAL25.3%

PRAX38349.0%

Gross Margin (TTM)

GRAL49.7%

PRAX0.0%

Operating Margin (TTM)

GRAL0.0%

PRAX0.0%

EBITDA Margin (TTM)

GRAL-229.0%

PRAX0.0%

Net Margin (TTM)

GRAL-236.9%

PRAX0.0%

FCF Margin (TTM)

GRAL-179.2%

PRAXN/A

Net Income (TTM)

GRAL$-392M

PRAX$-255M

FCF (TTM)

GRAL$-296M

PRAX$-306M

EPS (TTM)

GRAL-$9.08

PRAX$0.00

ROE (TTM)

GRAL-1588.0%

PRAX-4302.0%

ROA (TTM)

GRAL-1402.0%

PRAX-4022.0%

ROIC (TTM)

GRAL-1588.0%

PRAX-4302.0%

Cash

GRAL$56M

PRAX$475M

Debt

GRAL$0

PRAX$0

Net Cash/Debt

GRAL$56M

PRAX$475M

Current Ratio (TTM)

GRAL10.95x

PRAX15.73x

Quick Ratio (TTM)

GRAL10.55x

PRAX15.46x

Debt/Equity (TTM)

GRAL0.00x

PRAX0.00x

Debt/Assets (TTM)

GRAL0.0%

PRAX0.0%

Interest Coverage (TTM)

GRALN/A

PRAXN/A

Net Debt/EBITDA (TTM)

GRAL0.00x

PRAX0.00x

Beta

GRAL2.04

PRAX2.88

52W Performance

GRAL123.8%

PRAX378.7%

YTD Performance

GRAL58.2%

PRAX-9.3%

% from 52W High

GRAL-15.6%

PRAX-33.8%

% from 52W Low

GRAL238.7%

PRAX414.0%

Asset Turnover (TTM)

GRAL0.06x

PRAX0.02x

FCF Yield (TTM)

GRAL-4.9%

PRAX-4.2%

Earnings Yield (TTM)

GRAL-6.5%

PRAX-3.5%

Dividend Yield (TTM)

GRALN/A

PRAXN/A

Rule of 40

GRAL-156.1

PRAX0.0

EV/GP/RG

GRAL2.75

PRAXN/A

Ticker research

View GRAL research View PRAX research

Metric	GRAL Grail Inc	PRAX Praxis Precision Medicines Inc
Market & Valuation
Market Cap	$6.03B	$7.24B
Enterprise Value	$5.98B	$6.77B
Price	$140.58	$259.86
P/E Ratio	N/A	N/A
P/S Ratio	36.51x	964.65x
EV/Sales	36.17x	909.14x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.52x	6.15x
P/FCF Ratio	N/A	N/A
EV/FCF	-20.19x	-22.11x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	29.71x	67.04x
Revenue & Growth
Revenue (TTM)	$165M	$0
Revenue Growth (YoY)	23.1%	N/A
Forward Rev Growth	25.3%	38349.0%
Profitability
Gross Margin (TTM)	49.7%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-229.0%	0.0%
Net Margin (TTM)	-236.9%	0.0%
FCF Margin (TTM)	-179.2%	N/A
Net Income (TTM)	$-392M	$-255M
FCF (TTM)	$-296M	$-306M
EPS (TTM)	-$9.08	$0.00
ROE (TTM)	-1588.0%	-4302.0%
ROA (TTM)	-1402.0%	-4022.0%
ROIC (TTM)	-1588.0%	-4302.0%
Financial Health
Cash	$56M	$475M
Debt	$0	$0
Net Cash/Debt	$56M	$475M
Current Ratio (TTM)	10.95x	15.73x
Quick Ratio (TTM)	10.55x	15.46x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.04	2.88
52W Performance	123.8%	378.7%
YTD Performance	58.2%	-9.3%
% from 52W High	-15.6%	-33.8%
% from 52W Low	238.7%	414.0%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.02x
FCF Yield (TTM)	-4.9%	-4.2%
Earnings Yield (TTM)	-6.5%	-3.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-156.1	0.0
EV/GP/RG	2.75	N/A
Ticker research	View GRAL research	View PRAX research